MacroGenics Investors Call to Action
On September 11, 2024, The Schall Law Firm, a stalwart in shareholder rights litigation, casts a summons for investors, beckoning them to join forces in a class action lawsuit against MacroGenics, Inc. under violations of the Securities Exchange Act of 1934.
During the period between March 7, 2024, and May 9, 2024, investors who endorsed MacroGenics’ securities, ensnared in what is known as the “Class Period,” are urged to commune with the firm before September 24, 2024.
Those who’ve incurred losses from their investments can take a stand by participating in the lawsuit. The rendezvous is set with Brian Schall of The Schall Law Firm, stationed at Century Park East in Los Angeles.
In this developing saga, the Company stands accused of disseminating mendacious statements, cloaking the market with false assurance regarding the early trial results of the TAMARACK Phase 2 study. However, come May 9, the facade crumbled as updated data on safety and efficacy of their cancer treatment study painted a different picture.
Should you find yourself amongst those deceived, apathy is not an option. Unite with the lawsuit to restore your financial integrity and recoup your losses.
The Schall Law Firm prides itself on traversing the global financial landscape, dedicated to upholding shareholders’ rights through top-tier litigation services.
Remember, this press release may serve as Attorney Advertising in specific jurisdictions, in accordance with local laws and ethical regulations.
Contact:
The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com
View original content to download multimedia: https://www.prnewswire.com/news-releases/mgnx-investors-have-opportunity-to-lead-macrogenics-inc-securities-fraud-lawsuit-with-the-schall-law-firm-302243574.html
SOURCE The Schall Law Firm
